Recent Finacing
Recent Raise
Arginetix is a Baltimore biotech developing small-molecule arginase inhibitors to treat endothelial dysfunction across cardiovascular and pulmonary indications, including pulmonary arterial hypertension, atherosclerosis, and asthma.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
